Past infections may shape your COVID booster’s punch against Omicron

This in-depth study examines how previous immunity impacts the effectiveness of COVID-19 booster vaccinations and susceptibility to Omicron breakthrough infections. The research highlights the significant role of individual immune histories in shaping both humoral and cellular responses to SARS-CoV-2, urging for more tailored vaccine strategies.

After Phase 3 win, Arrowhead’s RNAi chases Ionis to market entry in rare genetic disorder

Arrowhead Pharmaceuticals’ RNAi treatment has succeeded in a registrational test in patients with an ultra-rare lipid metabolism disorder, bolstering plans for a regulatory filing that

June 4, 2024

US lawmakers urge administration to take action against Wuxi – Pharmaceutical Technology

Share this article WuXi has signed a number of partnerships that have strengthened its global reach. Credits: 010110010101101/Shutterstock.com In a letter to the US Departments

February 14, 2024

Eculizumab Substantially Reduces Myasthenia Gravis Events

PHOENIX – Generalized myasthenia gravis patients had dramatically lower incidence of flares and crises after starting on the complement component 5 inhibitor eculizumab (Soliris), data

November 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.